Literature DB >> 14513696

[Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].

Isabel Folatre1, Paola Zolezzi, Daniela Schmidt, Francisco Marín, Marlis Täger.   

Abstract

BACKGROUND: Infections caused by Varicella Zoster virus in children with cancer have a high rate of complications and mortality. AIM: To report the outcome of this infection in children with cancer. PATIENTS AND METHODS: Retrospective analysis of medical records of 216 children aged less than 15 years old with the diagnosis of an hematological or solid tumor, admitted to the National Program of Antineoplastic Drugs (PINDA).
RESULTS: Eighty seven children had a Varicella Zoster virus infections, 73 (84%) had varicella, 8 (9%) had herpes zoster and 6 (7%) had varicella and herpes zoster. Ninety four percent acquired the infection during antineoplastic treatment and 78% received Acyclovir as antiviral therapy. During a nosocomial outbreak of varicella, three patients with an Acute Lymphoblastic leukemia died in the initial phase of chemotherapy, in spite of an early administration of Acyclovir. No patient with herpes zoster died.
CONCLUSIONS: The incidence of varicella was higher in children with leukemia or lymphoma than in children with other types of cancer. Virus reactivation was uncommon and had a benign course. Varicella mortality in these children could be favorably modified through an active immunization of immunocompetent children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513696

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Incidence and consequences of varicella in children treated for cancer in Guatemala.

Authors:  Amy E Caruso Brown; Edwin J Asturias; Mario Melgar; Federico A Antillon-Klussmann; Pamela Mettler; Myron J Levin
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.

Authors:  Verena Wiegering; Judith Schick; Meinrad Beer; Benedikt Weissbrich; Stefan Gattenlöhner; Hermann J Girschick; Johannes Liese; Paul G Schlegel; Matthias Eyrich
Journal:  BMC Pediatr       Date:  2011-05-10       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.